A brief history of corporate tax inversion In 1982, McDermott Inc., an industrial company making nuclear reactor parts for the US Navy as well as deepsea oil and gas production facilities, decided to expatriate to Panama where one of their subsidiaries were located and renamed themselves McDermott International (Hines, 1991). This was done by having […]
Tax Inversions: Regulation Chasing Corporate Tax Loopholes Part 2
Corporate Tax impact on the Economy It is well documented through economic circles that taxes skew relative prices by shifting the supply curve to the left in a standard supply-demand model to create a deadweight loss. The deadweight loss is the area of the subsequent triangle with the endpoints at the pre-tax equilibrium, the supply […]
Tax Inversions: Regulation Chasing Corporate Tax Loopholes Part 1
The following was a research project completed for my Economics of Regulation class about tax inversions, the implications, and proposed solutions. Since this is a large paper, it will be split into 6 parts and published daily. Abstract – Corporate inversions have grown in popularity in recent years, and has drawn quite a bit of […]
Catatonic Economics – No one is talking about the greatest risk to America
Financial markets talk about a lot of headwinds to the economy. China devaluation, negative S&P earnings, presidential race, central bank actions, European banking problems, Japan, oil, etc. One that should be frontline news… more than the Trump tape, more than Kim Kardashian being (fake?) mugged, more than a backup QB kneeling for the national anthem. […]
July 28 Biotech Update
It is a mixed bag today in terms of stock reactions but the actual numbers continue to be good. I am not exactly sure why some stocks are reacting better than others but I will take a stab at it. In any case, it is hard to argue that the fundamentals of the sector do […]
Catatonic Economics
***”Economists have forecast 9 out of the last 5 recessions. *** One contribution I make to the CRG team is my background in economics. I have a pervasive interest in macroeconomics and am close to getting my Masters in Economics. I have worked for an economic indicator at the US Census Bureau, and work as […]
Biotech Inflection Point – Watch List-2
Following my last technical analysis “Biotech Inflection Point – Watch List-1” I will keep adding names to our watch list with some beaten down tickers, we can find many deep value biotech stocks in the recent pullback, some are trading at or very close to their cash level, at this point their assets are […]
Biotech Inflection Point – Watch List-1
Following my last technical analysis “XBI – A Look At The Near and Long Term In The Biotech Sector” I will start adding names to our watch list with some beaten down tickers, we can find many deep value biotech stocks in the recent pullback, some are trading at or very close to their cash […]
XBI – A Look At The Near and Long Term In The Biotech Sector
SPDR S&P Biotech ETF (XBI)–NYSE We will maintain our focus on the XBI as the biotech barometer, many are waiting for the XBI to outperform the IBB again and lead the way to a real recovery, to give us the sign that the technical correction is done and we are back to a […]
The XBI In The Take Or Break Zone!
SPDR S&P Biotech ETF (XBI)–NYSE We will maintain our focus on the XBI as the biotech barometer. After the double bottom around 59 points a month ago, the XBI start printing a higher high and a higher low, the first step in the new uptrend that we are looking for. Looking again at […]
A Quick look – XBI In The Decision Zone
SPDR S&P Biotech ETF (XBI) We will maintain our focus on the XBI as the biotech barometer. Noticing lately the fact XBI is outperforming the IBB & the broader market SPY or SPX, might give us the sense that investors are again, willing to take more risk with the small-mid cap biotech companies after the […]
August 21 Biotech Update
So it is obviously getting rough and we got our first peeks of panic yesterday. Most everyone seems to think that the worst is yet to come and I would not be surprised to see even more downside but obviously the contrarian in me wants to move to the other side of the boat when […]
Week’s Option Activity (7/15~7/19)
The following stocks had notable activity in their options during the past week: $NEPT (7/16): 16,000 (separated into trades of 6,000 and 10,000) AUG 4.0 strike Calls (stock at $3.71) were sold for 0.20 or total proceeds of $320,000. This trade is most likely a covered Call trade of an existing long stock position. $BCRX […]
